DEF 14A Filing

Company

Alaunos Therapeutics, Inc.

Filed

March 28, 2007

Period of Report

April 25, 2007

Accession Number

0001144204-07-014984

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →